4/A: Know Labs Director John Cronin Amends Form 4 Filing to Correct Transaction Date

John Cronin, a director at Know Labs, filed an amended Form 4 to correct the date of the earliest transaction from September 11, 2024, to September 24, 2024, while also reporting the acquisition of an option to purchase 1,000,000 shares of common stock.

Summary

• John Cronin, a director of Know Labs, Inc., filed an amendment to his Form 4 filing with the SEC.
• The amendment corrects the date of the earliest transaction from September 11, 2024, to September 24, 2024.
• The filing also reports the acquisition of an option to purchase 1,000,000 shares of Know Labs common stock.
• This option has an exercise price of $0.299 and expires on September 11, 2029.
• The option becomes exercisable ratably over a four-year period from the date of grant.
• Cronin directly owns 16,164 shares of common stock.
• Cronin also holds options to purchase 100,000 shares at $0.25 expiring on October 10, 2028, 100,000 shares at $0.34 expiring on November 10, 2028, and 290,411 shares at $0.49 expiring on February 8, 2029.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing correcting a date and reporting an option grant. While the option grant could be seen as positive, it's not a definitive indicator of future performance.

Positives

• The acquisition of a significant option position by a director could be interpreted as a sign of confidence in the company's future prospects.

Risks

• The filing itself doesn't inherently present risks, but it's important to monitor insider transactions for potential insights into company performance and future expectations.

Future Outlook

The document does not contain any specific forward-looking statements about the company's future performance, but the option grant suggests a potential belief in future growth.

Industry Context

Form 4 filings are a routine part of corporate governance and provide transparency into the transactions of company insiders. Monitoring these filings can offer insights into management's sentiment and potential future actions.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The option grant could potentially incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

Form 4, insider trading, Know Labs, John Cronin, options, common stock, amendment, director